Fig. 2. Effect of Arctigenin on cell viability in FaDu pharyngeal carcinoma cells.
The effect of Arctigenin on the viability of L-929 cells (A) and FaDu cells (B) was accessed by the MTT assay. The percentage of cell viability was calculated as a ratio of A570nms of Arctigenin treated with cells and untreated control cells. Each data point represents the mean ± SEM of four experiments. MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide. **p < 0.01 vs. control and ***p < 0.001 vs. control (the control cells measured in the absence of Arctigenin).
© Korean J Physiol Pharmacol
